Ellagic acid can improve stroke by regulating gut microbiota

Area of Science:

• Neuroscience
• Microbiology
• Pharmacology

Background:

• Stroke leads to significant morbidity, mortality, and disability, necessitating improved rehabilitation strategies.
• The microbiota-gut-brain axis is a key communication pathway implicated in stroke pathogenesis and gastrointestinal complications.
• Gut microbiota dysbiosis is increasingly recognized as a factor influencing stroke development and prognosis.

Purpose of the Study:

• To review the role of ellagic acid in modulating the gut microbiota for stroke recovery.
• To analyze the in vivo metabolism, biological activities, and therapeutic potential of ellagic acid.
• To identify strategies for overcoming ellagic acid's limitations, such as poor bioavailability.

Main Methods:

• Systematic analysis of in vivo metabolism of ellagic acid.
• Review of existing literature on ellagic acid, gut microbiota, and stroke.
• Evaluation of ellagic acid's anti-inflammatory and antioxidant properties.

Main Results:

• Ellagic acid demonstrates anti-inflammatory and antioxidant properties with potential to modulate gut microbiota.
• In vivo metabolism studies elucidate key biological activities and therapeutic potentials of ellagic acid.
• Limited bioavailability and solubility are identified as key limitations for ellagic acid's clinical application.

Conclusions:

• Ellagic acid shows promise in ameliorating stroke outcomes through gut microbiota modulation.
• Development of advanced drug delivery systems and novel ellagic acid derivatives can enhance efficacy.
• Targeting the microbiota-gut-brain axis with ellagic acid offers a promising therapeutic strategy for stroke rehabilitation.